Linch DC - Search Results

1

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study.

Das-Gupta E, Thomson KJ, Bloor AJC, Clark AD, Mackinnon S, Kayani I, Clifton-Hadley L, Patrick P, El-Mehidi N, Lawrie A, Kirkwood AA, Russell NH, Linch DC, Peggs KS. Das-Gupta E, et al. Among authors: linch dc. Blood Adv. 2019 Dec 23;3(24):4264-4270. doi: 10.1182/bloodadvances.2019001016. Blood Adv. 2019. PMID: 31869413 Free PMC article.

2

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma.

Morris E, Thomson K, Craddock C, Mahendra P, Milligan D, Cook G, Smith GM, Parker A, Schey S, Chopra R, Hatton C, Tighe J, Hunter A, Peggs K, Linch D, Goldstone A, Mackinnon S. Morris E, et al. Blood. 2004 Dec 15;104(13):3865-71. doi: 10.1182/blood-2004-03-1105. Epub 2004 Aug 10. Blood. 2004. PMID: 15304395 Free article.

3

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

Peggs KS, Thomson K, Hart DP, Geary J, Morris EC, Yong K, Goldstone AH, Linch DC, Mackinnon S. Peggs KS, et al. Among authors: linch dc. Blood. 2004 Feb 15;103(4):1548-56. doi: 10.1182/blood-2003-05-1513. Epub 2003 Oct 23. Blood. 2004. PMID: 14576063 Free article. Clinical Trial.

4

The role of allogeneic transplantation in non-Hodgkin's lymphoma.

Peggs KS, Mackinnon S, Linch DC. Peggs KS, et al. Among authors: linch dc. Br J Haematol. 2005 Jan;128(2):153-68. doi: 10.1111/j.1365-2141.2004.05251.x. Br J Haematol. 2005. PMID: 15638849 Free article. Review.

5

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.

Peggs KS, Hunter A, Chopra R, Parker A, Mahendra P, Milligan D, Craddock C, Pettengell R, Dogan A, Thomson KJ, Morris EC, Hale G, Waldmann H, Goldstone AH, Linch DC, Mackinnon S. Peggs KS, et al. Among authors: linch dc. Lancet. 2005 Jun 4-10;365(9475):1934-41. doi: 10.1016/S0140-6736(05)66659-7. Lancet. 2005. PMID: 15936420

6

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

Bloor AJ, Thomson K, Chowdhry N, Verfuerth S, Ings SJ, Chakraverty R, Linch DC, Goldstone AH, Peggs KS, Mackinnon S. Bloor AJ, et al. Among authors: linch dc. Biol Blood Marrow Transplant. 2008 Jan;14(1):50-8. doi: 10.1016/j.bbmt.2007.04.013. Biol Blood Marrow Transplant. 2008. PMID: 18158961 Free article.

7

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma.

Thomson KJ, Morris EC, Bloor A, Cook G, Milligan D, Parker A, Clark F, Yung L, Linch DC, Chakraverty R, Peggs KS, Mackinnon S. Thomson KJ, et al. Among authors: linch dc. J Clin Oncol. 2009 Jan 20;27(3):426-32. doi: 10.1200/JCO.2008.17.3328. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064981

8

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma.

Lambert JR, Bomanji JB, Peggs KS, Thomson KJ, Chakraverty RK, Fielding AK, Kottaridis PD, Roughton M, Morris EC, Goldstone AH, Linch DC, Ell PJ, Mackinnon S. Lambert JR, et al. Among authors: linch dc. Blood. 2010 Apr 8;115(14):2763-8. doi: 10.1182/blood-2009-11-255182. Epub 2010 Feb 2. Blood. 2010. PMID: 20124510 Free article.

9

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning.

Mead AJ, Thomson KJ, Morris EC, Mohamedbhai S, Denovan S, Orti G, Fielding AK, Kottaridis PD, Hough R, Chakraverty R, Linch DC, Mackinnon S, Peggs KS. Mead AJ, et al. Among authors: linch dc. Blood. 2010 Jun 24;115(25):5147-53. doi: 10.1182/blood-2010-01-265413. Epub 2010 Apr 6. Blood. 2010. PMID: 20371745 Free article.

10

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

Peggs KS, Kayani I, Edwards N, Kottaridis P, Goldstone AH, Linch DC, Hough R, Morris EC, Fielding A, Chakraverty R, Thomson KJ, Mackinnon S. Peggs KS, et al. Among authors: linch dc. J Clin Oncol. 2011 Mar 10;29(8):971-8. doi: 10.1200/JCO.2010.32.1711. Epub 2011 Jan 31. J Clin Oncol. 2011. PMID: 21282545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

502 results

Search Page